We would like to thank everyone involved in the 2024 Kolling Institute Symposium. During the event, a diverse collection of researchers detailed the latest progress with their ground-breaking work into kidney and heart disease treatments, bone and muscle conditions, rare cancers, and neurological challenges. There was a focus too on the innovative work to develop a unique wellbeing index. Researche.....
Read more

Our Kolling Institute newsletter brings together a collection of profiles on our impressive researchers. Flip through our flipping book to discover more about our leading research into kidney disease, rare cancers and the use of supplements for osteoarthritis. There's a focus too on the first steps towards gene therapy for Meniere's disease, the latest research into treatments for dementia and.....
Read more

In the heart of the Kolling Institute, a world-renowned research centre, a raft of clinical trials is driving the future of healthcare. “Clinical trials are intrinsic to research,” says Professor James Elliott, Academic Director of the institute. “They help us test something so that we can better inform care for patients with various conditions who come to our hospitals for treatment.” The Kolling .....
Read more

Our researchers at the Kolling Institute are at the forefront of Meniere’s disease science developing the first humanised model of the disease ahead of gene therapy. The specialised team is led by world-leading Meniere’s disease researcher and neuroscientist Professor Jose Antonio Lopez-Escamez who relocated from Spain to the institute to pursue his ground-breaking work. His talented team of seven .....
Read more

Our Kolling Institute Year in Review profiles our innovative and life-changing research across the Kolling Institute. Our researchers are driving investigations into some of the most challenging health conditions from heart and kidney disease to musculoskeletal conditions, chronic pain, cancer and neurodegenerative disorders. Our teams have continued to increase their research impact, while forging.....
Read more

A team of researchers from the Kolling Institute’s John Walsh Centre for Rehabilitation Research has launched a study to develop the first internationally accepted guidelines for assessing cognitive function after a spinal cord injury. The latest data indicates that over 15 million people globally live with a spinal cord injury, and in Australia, there are over 20,000 people living with the injury......
Read more

It is with great sadness that the Kolling Institute acknowledges the passing of Professor John Walsh AO. Professor Walsh had a longstanding relationship with many researchers across the Kolling and the local health district and was immensely respected by his colleagues. Having a background as an actuary, Professor Walsh applied his expertise to many projects over his life, specifically policy devel.....
Read more

It has taken three years and many hours of careful work, but two researchers from the John Walsh Centre for Rehabilitation Research have developed the first clinical practice guidelines for physiotherapists to inform the care of people with life-changing spinal cord injuries. Physiotherapy is a key part of rehabilitation for people with a spinal cord injury, but until now, there has been no nationa.....
Read more

We would like to acknowledge the remarkable life of pain medicine pioneer and former Royal North Shore Hospital specialist Professor Michael Cousins AO who has sadly passed away. Michael was a trailblazer in anaesthesia and pain medicine, and a mentor to many at the Kolling Institute and on the Royal North Shore Hospital campus. With a career spanning more than 50 years, Michael dedicated his life .....
Read more

A collection of researchers will develop their skills and establish crucial new collaborations following generous funding through the Skipper Charitable Trust. Six researchers have received a 2024 Beryl and Jack Jacobs Travel Award, enabling them to travel for conferences and work with experts across the globe. Academic Director Professor James Elliott was thrilled to announce the successful recipi.....
Read more